| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |